Literature DB >> 11359490

A correlation of alpha-smooth muscle actin and invasion in micronodular basal cell carcinoma.

M M Christian1, R L Moy, R F Wagner, A Yen-Moore.   

Abstract

BACKGROUND: Actin is largely responsible for cell motility and is only sparsely found in normal epithelial cells. An altered expression of actin in some malignancies may facilitate aggressive invasion. Micronodular basal cell carcinoma (BCC) has been shown to require more surgical stages, wider tissue margins, and deeper defects for extirpation during Mohs micrographic surgery relative to nodular BCC.
OBJECTIVE: To provide preliminary data regarding a possible correlation between alpha-smooth muscle actin (alpha-SMA) expression within the cells or stroma of micronodular BCC and aggressive invasion. In addition, the incidence of alpha-SMA expression in micronodular, morpheaform, and nodular BCC is evaluated.
METHODS: Nine micronodular basal cell carcinomas (7 primary, 2 recurrent) were evaluated for neural invasion, depth of tissue invasion, and alpha smooth muscle actin antibodies. The presence of alpha-smooth muscle actin antibodies was assessed using immunoperoxidase staining and compared with 13 morpheaform (13 primary, 0 recurrent) and 12 nodular (12 primary, 0 recurrent).
RESULTS: Six of the nine micronodular (67%), eight of the 13 morpheaform (62%), and 0 of the 12 nodular (0%) BCCs stained positive for alpha-SMA. Of the six micronodular BCCs that stained positive for alpha-SMA, three invaded the fascia or muscle and three displayed neural invasion. In contrast, of the three micronodular BCCs that stained negative for alpha-SMA, none invaded the fascia or muscle and only one exhibited neural invasion.
CONCLUSION: Actin was present in 66% of micronodular, 62% of morpheaform, and 0% of nodular BCC. The presence of actin in micronodular BCC may be a marker for aggressive invasion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359490     DOI: 10.1046/j.1524-4725.2001.00200.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  10 in total

1.  Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs.

Authors:  Ekaterina Schreiber-Brynzak; Erik Klapproth; Christine Unger; Irene Lichtscheidl-Schultz; Simone Göschl; Sarah Schweighofer; Robert Trondl; Helmut Dolznig; Michael A Jakupec; Bernhard K Keppler
Journal:  Invest New Drugs       Date:  2015-06-21       Impact factor: 3.850

2.  EGFR signaling downstream of EGF regulates migration, invasion, and MMP secretion of immortalized cells derived from human ameloblastoma.

Authors:  Marina Rolo Pinheiro da Rosa; Aline Semblano Carreira Falcão; Hellen Thais Fuzii; Maria Sueli da Silva Kataoka; André L R Ribeiro; Enrique Boccardo; Adriane Sousa de Siqueira; Ruy G Jaeger; João de Jesus Viana Pinheiro; Sérgio de Melo Alves Júnior
Journal:  Tumour Biol       Date:  2014-08-07

3.  Aggressive basal cell carcinoma of the head and neck: challenges in surgical management.

Authors:  Peter J F M Lohuis; Anil Joshi; Pepijn A Borggreven; Lenka Vermeeren; Biljana Zupan-Kajcovski; Abrahim Al-Mamgani; Alfons J M Balm
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-11       Impact factor: 2.503

4.  Analysis of the occurrence and distribution of primary and recurrent basal cell carcinoma of head and neck coupled to the assessment of tumor microenvironment and Sonic hedgehog signaling.

Authors:  Jelena Moisejenko-Golubovica; Oleg Volkov; Anna Ivanova; Valerija Groma
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

5.  Differences in actin expression between primary and recurrent facial basal cell carcinomas as a prognostic factor of local recurrence.

Authors:  Katarzyna Iwulska; Grażyna Wyszyńska-Pawelec; Jan Zapała; Bogdan Kosowski
Journal:  Postepy Dermatol Alergol       Date:  2021-07-26       Impact factor: 1.837

6.  Nodular and Micronodular Basal Cell Carcinoma Subtypes Are Different Tumors Based on Their Morphological Architecture and Their Interaction with the Surrounding Stroma.

Authors:  Mircea-Sebastian Șerbănescu; Raluca Maria Bungărdean; Carmen Georgiu; Maria Crișan
Journal:  Diagnostics (Basel)       Date:  2022-07-05

7.  Immunoreactivity for alpha-smooth muscle actin characterizes a potentially aggressive subgroup of little basal cell carcinomas.

Authors:  L Pilloni; P Bianco; C Manieli; G Senes; P Coni; L Atzori; N Aste; G Faa
Journal:  Eur J Histochem       Date:  2009-06-29       Impact factor: 3.188

Review 8.  Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma.

Authors:  Mihai Lupu; Constantin Caruntu; Mihaela Adriana Ghita; Vlad Voiculescu; Suzana Voiculescu; Adrian E Rosca; Ana Caruntu; Liliana Moraru; Iris Maria Popa; Bogdan Calenic; Maria Greabu; Daniela Elena Costea
Journal:  Dis Markers       Date:  2016-08-08       Impact factor: 3.434

9.  Evaluation of Immunohistochemical Findings and Clinical Features Associated with Local Aggressiveness in Basal Cell Carcinoma.

Authors:  Simin ShamsiMeymandi; Shahriar Dabiri; Alireza ZeynadiniMeymand; Maryam Iranpour; Maryam Khalili; Sorour Alijani; Mahin Aflatoonian
Journal:  Iran J Pathol       Date:  2019-08-01

10.  The Role of Actin in Muscle Spasms in a Case Series of Patients with Advanced Basal Cell Carcinoma Treated with a Hedgehog Pathway Inhibitor.

Authors:  Natalie Teh; Liang Joo Leow
Journal:  Dermatol Ther (Heidelb)       Date:  2020-11-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.